Park National Corp’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.27M Buy
6,329
+5,787
+1,068% +$3.44M 0.12% 116
2026
Q2
$272K Sell
542
-25
-4% -$12K 0.01% 283
2026
Q1
$279K Buy
+567
New +$308K 0.01% 283
2024
Q3
– Sell
-379
Closed -$210K – 303
2024
Q2
$210K Buy
379
+23
+6% +$13.2K 0.01% 283
2024
Q1
$207K Buy
+356
New +$200K 0.01% 279
2023
Q2
– Sell
-376
Closed -$217K – 288
2023
Q1
$217K Buy
376
+6
+2% +$3.38K 0.01% 251
2022
Q4
$204K Buy
+370
New +$196K 0.01% 265
2018
Q3
– Sell
-1,243
Closed -$258K – 365
2018
Q2
$258K Sell
1,243
-103
-8% -$21.9K 0.01% 284
2018
Q1
$278K Buy
+1,346
New +$283K 0.02% 281

Other funds holding TMO

Park National Corp's TMO Position: Q3 2026 in Review

Park National Corp increased its Thermo Fisher Scientific (TMO) stake by 1,068% in Q3 2026, buying an estimated $3.44M and bringing the position to 6,329 shares worth $4.27M. The position accounts for 0.12% of the portfolio, ranked #116.

Park National Corp first reported a position in TMO in Q1 2018 and has held it in 9 quarters since. 134 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Park National Corp held 6,329 shares of Thermo Fisher Scientific worth $4.27M as of Q3 2026.
  • Park National Corp bought 5,787 Thermo Fisher Scientific shares in Q3 2026, an estimated $3.44M.
  • Thermo Fisher Scientific made up 0.12% of Park National Corp's portfolio in Q3 2026, its #116 holding.
  • Park National Corp first reported a position in Thermo Fisher Scientific in Q1 2018 and has held it in 9 quarters since.
  • 134 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Park National Corp's 13F filing for Q3 2026, filed 5 Oct 2026.